What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?
Petrini P. Petrini P.
. Aminian A, et al. Diabetes Care. 2021 Sep 9:dc203023. doi: 10.2337/dc20-3023. Online ahead of print. Diabetes Care. 2021. PMID: 34503954
.
![top](data:image/svg+xml,%3Csvg%20xmlns="http://www.w3.org/2000/svg"%20width="16"%20height="16"%3E%3Crect%20fill-opacity="0"/%3E%3C/svg%3E "top")
